TITLE:
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes

CONDITION:
Diabetes

INTERVENTION:
human insulin

SUMMARY:

      This trial is conducted in the United States of America (USA). The purpose of this study is
      to test whether NovoLog (insulin aspart) is a safe and at least as effective alternative to
      regular human insulin for the control of blood glucose after meals in women who develop
      diabetes during pregnancy.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Subjects older than 35 years old will be considered

          -  Gestational diabetes mellitus
      
